LMS to delist from Amex
May 01 2008 - 9:22AM
PR Newswire (US)
MONTREAL, May 1 /PRNewswire-FirstCall/ -- LMS Medical Systems (TSX:
LMZ, AMEX: LMZ), a healthcare technology company and developer of
the CALM- patient safety software system for obstetrics, today
announced that its Board of Directors has unanimously decided to
delist the Company's common shares from Amex. The decision is in
keeping with the Company's previous announcement to streamline
operations and control costs in order to become cash flow positive.
It is expected that Amex trading will cease on or about May 22,
2008. LMS common shares will continue to be traded on the Company's
principal exchange, the TSX. About LMS: LMS is a leader in the
application of advanced mathematical modeling and neural networks
for medical use. The LMS CALM Suite provides physicians, nursing
staff, risk managers and hospital administrators with clinical
information systems and risk management tools designed to improve
outcomes and patient care for mothers and their infants during
childbirth. Except for historical information contained herein, the
matters discussed in this news release are forward-looking
statements. Because these forward-looking statements involve risks
and uncertainties, there are important factors that could cause
actual results to differ materially from those expressed implied by
the forward-looking statements including, but without limitation,
economic conditions in general and in the healthcare market, the
demand for and market for our products in domestic and
international markets, our current dependence on the CALM product
suite, the challenges associated with developing new products and
obtaining regulatory approvals if necessary, research and
development activities, the uncertainty of acceptance of our
products by the medical community, the lengthy sales cycle for our
products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by
others, our dependence on our distributors, physician training,
enforceability and the costs of enforcement of our patents,
potential infringements of our patents and the other factors set
forth from time to time in the Company's filings with the United
States Securities and Exchange Commission and with the Canadian
Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Yves Grou, Chief
Financial Officer, LMS Medical Systems Inc., (514) 488-3461 Ext.
238, Fax: (514) 488-1880, , http://www.lmsmedical.com/
Copyright